These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

475 related articles for article (PubMed ID: 24225201)

  • 81. Effectiveness and Tolerability of Ivabradine with or Without Concomitant Beta-Blocker Therapy in Patients with Chronic Stable Angina in Routine Clinical Practice.
    Perings S; Stöckl G; Kelm M;
    Adv Ther; 2016 Sep; 33(9):1550-64. PubMed ID: 27432382
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Cardiovascular function and prognosis of patients with heart failure coexistent with chronic obstructive pulmonary disease.
    Yoshihisa A; Takiguchi M; Shimizu T; Nakamura Y; Yamauchi H; Iwaya S; Owada T; Miyata M; Abe S; Sato T; Suzuki S; Oikawa M; Kobayashi A; Yamaki T; Sugimoto K; Kunii H; Nakazato K; Suzuki H; Saitoh S; Takeishi Y
    J Cardiol; 2014 Oct; 64(4):256-64. PubMed ID: 24674751
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Acute hemodynamic effects of tolvaptan, a vasopressin V2 receptor blocker, in patients with symptomatic heart failure and systolic dysfunction: an international, multicenter, randomized, placebo-controlled trial.
    Udelson JE; Orlandi C; Ouyang J; Krasa H; Zimmer CA; Frivold G; Haught WH; Meymandi S; Macarie C; Raef D; Wedge P; Konstam MA; Gheorghiade M
    J Am Coll Cardiol; 2008 Nov; 52(19):1540-5. PubMed ID: 19007589
    [TBL] [Abstract][Full Text] [Related]  

  • 84. [Heart rate and outcome in patients with acute and chronic heart failure].
    Oliva F; Ammirati E; Campana C; Carubelli V; Cirò A; Di Tano G; Mortara A; Senni M; Morandi F; Metra M
    G Ital Cardiol (Rome); 2016 Mar; 17(3 Suppl 1):3S-16. PubMed ID: 27030005
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Diagnostic and therapeutic challenges in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure.
    Le Jemtel TH; Padeletti M; Jelic S
    J Am Coll Cardiol; 2007 Jan; 49(2):171-80. PubMed ID: 17222727
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Ivabradine for the treatment of chronic heart failure.
    Henri C; O'Meara E; De Denus S; Elzir L; Tardif JC
    Expert Rev Cardiovasc Ther; 2016; 14(5):553-61. PubMed ID: 26967048
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Chronic obstructive pulmonary disease in heart failure. Prevalence, therapeutic and prognostic implications.
    Mascarenhas J; Lourenço P; Lopes R; Azevedo A; Bettencourt P
    Am Heart J; 2008 Mar; 155(3):521-5. PubMed ID: 18294490
    [TBL] [Abstract][Full Text] [Related]  

  • 88. The effect of ivabradine on functional capacity in patients with chronic obstructive pulmonary disease.
    Mahmoud K; Kassem HH; Baligh E; ElGameel U; Akl Y; Kandil H
    Clin Med (Lond); 2016 Oct; 16(5):419-422. PubMed ID: 27697801
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Bronchodilators in heart failure patients with COPD: is it time for a clinical trial?
    Mentz RJ; Fiuzat M; Kraft M; Lindenfeld J; O'Connor CM
    J Card Fail; 2012 May; 18(5):413-22. PubMed ID: 22555273
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Prognostic influence of prior chronic obstructive pulmonary disease in patients admitted for their first episode of acute heart failure.
    Londoño KL; Formiga F; Chivite D; Moreno-Gonzalez R; Migone De Amicis M; Corbella X
    Intern Emerg Med; 2018 Apr; 13(3):351-357. PubMed ID: 29508227
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Levosimendan versus dobutamine in heart failure patients treated chronically with carvedilol.
    Duygu H; Turk U; Ozdogan O; Akyuz S; Kirilmaz B; Alioglu E; Gunduz R; Bozkaya YT; Turkoglu C; Payzin S
    Cardiovasc Ther; 2008; 26(3):182-8. PubMed ID: 18786088
    [TBL] [Abstract][Full Text] [Related]  

  • 92. [Chronic obstructive pulmonary disease on inpatients with heart failure. GESAIC study results].
    Recio-Iglesias J; Grau-Amorós J; Formiga F; Camafort-Babkowski M; Trullàs-Vila JC; Rodríguez A;
    Med Clin (Barc); 2010 Apr; 134(10):427-32. PubMed ID: 20149399
    [TBL] [Abstract][Full Text] [Related]  

  • 93. [Heart failure: critical patients].
    Fabbri G; Gorini M; Maggioni AP; Oliva F;
    G Ital Cardiol (Rome); 2007 Sep; 8(9):568-73. PubMed ID: 17972426
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Ivabradine in combination with metoprolol succinate in the treatment of inappropriate sinus tachycardia.
    Ptaszynski P; Kaczmarek K; Ruta J; Klingenheben T; Cygankiewicz I; Wranicz JK
    J Cardiovasc Pharmacol Ther; 2013 Jul; 18(4):338-44. PubMed ID: 23426376
    [TBL] [Abstract][Full Text] [Related]  

  • 95. The impact of eplerenone at different levels of risk in patients with systolic heart failure and mild symptoms: insight from a novel risk score for prognosis derived from the EMPHASIS-HF trial.
    Collier TJ; Pocock SJ; McMurray JJ; Zannad F; Krum H; van Veldhuisen DJ; Swedberg K; Shi H; Vincent J; Pitt B
    Eur Heart J; 2013 Sep; 34(36):2823-9. PubMed ID: 23864130
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Ivabradine.
    Komajda M
    Handb Exp Pharmacol; 2017; 243():167-175. PubMed ID: 27752846
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Multicentric study on the beta-blocker use and relation with exacerbations in COPD.
    Puente-Maestu L; Calle M; Ortega-González A; Fuster A; González C; Márquez-Martín E; Marcos-Rodriguez PJ; Calero C; Rodríguez-Hermosa JL; Malo de Molina R; Aburto M; Sobradillo P; Alcázar B; Tirado-Conde G;
    Respir Med; 2014 May; 108(5):737-44. PubMed ID: 24635914
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Therapeutic update: non-selective beta- and alpha-adrenergic blockade in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure.
    Sirak TE; Jelic S; Le Jemtel TH
    J Am Coll Cardiol; 2004 Aug; 44(3):497-502. PubMed ID: 15358010
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Resting heart rate is a predictor of mortality in COPD.
    Jensen MT; Marott JL; Lange P; Vestbo J; Schnohr P; Nielsen OW; Jensen JS; Jensen GB
    Eur Respir J; 2013 Aug; 42(2):341-9. PubMed ID: 23143550
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Clinical characteristics, response to exercise training, and outcomes in patients with heart failure and chronic obstructive pulmonary disease: findings from Heart Failure and A Controlled Trial Investigating Outcomes of Exercise TraiNing (HF-ACTION).
    Mentz RJ; Schulte PJ; Fleg JL; Fiuzat M; Kraus WE; Piña IL; Keteyian SJ; Kitzman DW; Whellan DJ; Ellis SJ; O'Connor CM
    Am Heart J; 2013 Feb; 165(2):193-9. PubMed ID: 23351822
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.